COVID injections not tested in pregnant women

The US Food and Drug Administration (FDA) and Pfizer tried to hide data from clinical trials of COVID-19 injections for 75 years. This should have been a red flag to anyone, now we know why.

Since a lawsuit forced the FDA to release thousands of documents, information is coming to light about what they were trying to hide. Among the revelations is evidence that Pfizer deliberately excluded pregnant women from COVID-19 injection trials.

So how did they make the recommendation that the injections are safe and effective for pregnant women? This was based on a 42-day study of 44 rats. The doctors who conducted the study were either shareholders or employees of Pfizer and BioNTech’.

In addition, a Pfizer-BioNTech rat study revealed that the injection more than doubled the incidence of pre-implantation loss and also led to a low incidence of mouth/jaw malformations, gastroschisis (a birth defect of the abdominal wall) and anomalies of the right-sided aortic arch and cervical vertebrae in fetuses.

A study sponsored by the Centers for Disease Control and Prevention (CDC) that was widely used to support the recommendation that pregnant women be vaccinated according to the Institute of Pure and Applied Knowledge (IPAK).

When the risk of miscarriage was recalculated to include all women injected before 20 weeks gestation, the incidence was seven to eight times higher than indicated in the original study, with a cumulative incidence of miscarriage ranging from 82% to 91%.

Also buried in one of the documents is the statement: “Clinical laboratory evaluation showed a transient decrease in lymphocytes that was observed in all age and dose groups after dose 1, which resolved in approximately one week…”.

What this means is that Pfizer knew that in the first week after injection, people of all ages experienced transient immunosuppression, or in other words a temporary weakening of the immune system, after the first dose.

Pfizer and the FDA knew the injections were not “safe and effective”.

By August 2021, Pfizer and the FDA already knew they had failed, the injections were not safe and effective,” said research author Naomi Wolf. “That they weren’t working. That the efficacy was waning … and that they were seriously dangerous. And they launched it anyway.

Regarding the injections for pregnant women, Wolf said an increase in serious adverse events among pregnant women coincides with the launch of COVID-19 injections.

Whistleblowers at the US Department of Defense (DOD) analysed the DOD health database and revealed significant increases in the rates of miscarriages and stillbirths (a stillbirth is when a baby dies in the womb during the last 20 weeks of pregnancy, a miscarriage is fetal loss in the first half of pregnancy), along with cancer and neurological diseases, since COVID-19 injections were implemented.

Not only do the IPAK data show that COVID-19 injections before 20 weeks are unsafe for pregnant women, but 12.6% of women who received them in the third trimester reported Grade 3 adverse events, which are serious or medically significant but not immediately life-threatening.

Another 8% also reported fever of 38 degrees C (100.4 degrees F), which can lead to miscarriage or premature delivery.
Young children also develop severe hepatitis, and no one knows why.
COVID-19 injections have been linked to cases of liver disease, and liver damage following the injections has been considered possible.
The American College of Obstetricians and Gynecologists (ACOG) also made definitive statements about safety, stating that “vaccination can occur in any trimester, and emphasis should be placed on receiving the vaccine as early as possible to maximise maternal and fetal health”. However, even the Comirnaty label states that “the available data on Comirnaty administered to pregnant women are insufficient to inform the risks associated with the vaccine in pregnancy”.

The consent form also specifies that the effect on sperm, foetuses and nursing infants is unknown. However, health authorities and the media have stated as a “fact” that the injection does not affect reproductive health or fertility and is perfectly safe for pregnant and breastfeeding mothers.

If an effect is unknown, by definition it cannot be said to be harmless. The director of the Centers for Disease Control and Prevention, Dr. Rochelle Walensky, is just one of a long list of culprits for this. She has repeatedly assured the public that the shot poses no health risks to pregnant women or their babies.

Confirmed: K0B1T shots affect menstrual cycles
It is clear that there are many unknowns about how K0 B1T injections affect pregnancy and reproduction, including their effects on menstrual cycles. Women around the world have reported changes in their menstrual cycles after COVID-19 injections, and health officials have tried to ignore the reports or label them anecdotal.

But a study published in Obstetrics & Gynecology, and funded by the National Institute of Child Health and Human Development (NICHD) and the National Institutes of Health (NIH) Office of Research on Women’s Health, confirms an association between K0 B1T injections and menstrual cycle length.

Clinical trials for K0 B1T injections did not collect data on menstrual cycles after injection, and the Vaccine Adverse Event Reporting System (VAERS) does not actively collect menstrual cycle information either, making it difficult to initially determine whether the injections were having an effect.

However, reports on social media are numerous and, according to the study, “suggest that menstrual disorders are much more common…”.

The Obstetrics and Gynaecology study involved 3,959 people between the ages of 18 and 45. Those who had not received the K0 B1T injection did not notice significant changes in their cycles during the comparison study. However, those who received the K0 B1T injection had longer menstrual cycles than when they received the injections. Longer cycles were observed for both doses of the injection, with some women experiencing significant menstrual changes, particularly those who received two injections in the same menstrual cycle.

These changes included a two-day increase in cycle length and, in some cases, changes in cycle length of eight days or more.

Research conducted by the New York State Department of Health shows the reality about the effectiveness of COVID-19 injections in children.

From 13 December 2021 to 24 January 2022, they analysed results from 852,384 children aged 12 to 17 years and 365,502 children aged 5 to 11 years who had received two doses of the injections.

Effectiveness declined rapidly among 5-11 year olds, dropping from 68% to just 12%.

Protection against hospitalisation also declined, from 100% to 48%. Among 11-year-olds alone, vaccine effectiveness plummeted to 11%.

In the youngest age group, the injections provided almost no protection at all.

And it is not only children who are affected by the rapidly declining effectiveness of the injections.

The K0 B1T booster injections also lose efficacy rapidly, and protection plummets by the fourth month after injection. A CDC-funded study involved data from 10 states collected from 26 August 2021 to 22 January 2022, periods during which the delta and omicron variants circulated.

Visits to emergency rooms and urgent care centres, as well as hospitalisations, were analysed among people seeking care for COVID-19. The study did not include milder cases of COVID-19, for which no medical care was sought.

Effectiveness declined as time passed since vaccination. The low effectiveness five months after the initial series of injections is what led officials to recommend a booster dose. However, this booster was short-lived. Within four to five months after the booster.

Given the adverse effects and lack of efficacy, many have called for the immediate withdrawal of the injections. IPAK believes that the data are now compelling enough to withdraw the injections from vulnerable populations, including pregnant and breastfeeding women, children and people of childbearing age.

Janci Chunn Lindsay, Ph.D., a leading toxicologist and molecular biologist working with MD Anderson Cancer Center-Houston, spoke at the CDC’s Advisory Committee on Immunisation Practices meeting on 23 April 2021, and also called for “all gene therapy injections” to “be stopped immediately due to safety concerns on several fronts,” including fertility.

COVID-19 injections increase risk of heart attack by 25% in young people
Concluding the inquest into the woman’s death, assistant coroner Alison McCormick said: “I conclude that her death was caused by acute myocarditis, due to recent immunisation against covid-19.

Myocarditis is a recognised adverse effect of COVID-19 mRNA injections. Dr. Neil Singh Dhalla, executive director of a major health clinic, fell asleep four days after receiving a COVID-19 booster vaccine and died of a heart attack.

The autopsy indicated myocarditis. He was only 48 years old and had never had any heart problems in his life. In another example, epidemiologists confirmed that two teenagers from different US states died of myocarditis days after receiving the Pfizer injection.

Both had received second doses of the injection. In a study that examined the autopsy findings, it is reported that the “myocarditis” described in the children’s deaths “is not typical myocarditis pathology”:

“The myocardial injury observed in these post-vaccine hearts is different from typical myocarditis and has an appearance that more closely resembles a catecholamine-mediated (toxic) stress cardiomyopathy. Understanding that these cases are different from typical myocarditis and that the cytokine storm has a known feedback loop with catecholamines may help guide detection and therapy.”

A startling study published in Scientific Reports further revealed that calls to Israel’s National Emergency Medical Services (EMS) for cardiac arrest and acute coronary syndrome increased by more than 25% among people aged 16-39 years from January 2021 to May 2021, compared to the same time period in 2019 and 2020.

The researchers assessed the association between call volume and other factors, including COVID-19 injections and COVID-19 infection, but only found a link for injections :

“Weekly emergency call counts were significantly associated with rates of the first and second doses of vaccine administered to this age group, but not with rates of COVID-19 infection.

“Although causal relationships are not established, the findings raise concerns about undetected vaccine-induced serious cardiovascular side effects and underscore the already established causal relationship between the injections and myocarditis, a frequent cause of unexpected cardiac arrest in young people”.

It is absoulutely VITAL that you spread these articles and share them far and wide!!

There will never be ads, nor paywalls on this website and I do this almost daily, delivering 5 articles for free, so please donate if you can afford it!

Donations are NOT neccesary in any way, but ALWAYS appreciated.

You can also check my bitchute channel where I reupload videos with juicy info in them.

Stay up to date on telegram and minds!

Our spanish readers can also check the podcast, and watch the odysee channel.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s